Colecistitis Aguda Alitiásica

dialnet-ar-18-ART0001531010

dialnet

Dialnet

Dialnet AR

RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 2, 2022, pags. 520-526

Spanish

Colecistitis
Aguda
Alitiásica
Diagnóstico
Tratamiento
Cholecystitis
Acute
Acalculous
Diagnosis
Treatment

Colecistitis
Aguda
Alitiásica
Diagnóstico
Tratamiento
Cholecystitis
Acute
Acalculous
Diagnosis
Treatment
Calle Jara, Emanuel Francisco
Idrovo Campoverde, Paula Jessenia
Peralta Sánchez, Andrea Gabriela
Bermeo León, Karla Johanna
Quilli Guamán, Jonnathan Javier
Colecistitis Aguda Alitiásica

Acute acalculous cholecystitis (AAC) or also called acalculous, is a rare but emerging entity and often secondary to other clinical con-ditions, manifests the presence of gallbladder inflammation in the absence of stones inside. Acalculous cholecystitis accounts for the remaining 5-10% of cholecystitis and is typically seen in very ill patients or in the setting of severe injury with predisposing factors (diabetes mellitus, vasculitis, heart failure, shock, sepsis, etc.) Diagnosis it is imperative, given its propensity for progression to gangrene (greater than 50%) and perforation (10%), and should be considered in all critically ill patients with sepsis and/or jaundice. Consequently, the pres-ent investigation has the purpose of summarizing the diagnosis and treatment of Acute Acalculous Cholecystitis. Laboratory studies are not conclusive in all patients (in some cases), however, the most recommended are: blood count with leukocytosis, elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), increased bilirubins, transaminases, alkaline phosphatase, amylase. For diag-nosis by means of images, due to the cost-effectiveness relationship, the echosonogram or ultrasound is the most used. Early treatment decision is closely related to prognosis. Treatment of CAA must always include antibiotic therapy and supportive treatment with fluids, analgesics and an initial absolute diet. Cholecystectomy has historically been the treatment of choice, however, currently percutaneous cholecystostomy has become an effective and minimally invasive alternative, especially in patients with high surgical risk.

Article

Calle Jara, Emanuel Francisco
Idrovo Campoverde, Paula Jessenia
Peralta Sánchez, Andrea Gabriela
Bermeo León, Karla Johanna
Quilli Guamán, Jonnathan Javier

Calle Jara, Emanuel Francisco
Idrovo Campoverde, Paula Jessenia
Peralta Sánchez, Andrea Gabriela
Bermeo León, Karla Johanna
Quilli Guamán, Jonnathan Javier

Calle Jara, Emanuel Francisco

Colecistitis Aguda Alitiásica

Colecistitis Aguda Alitiásica

Colecistitis Aguda Alitiásica

Colecistitis Aguda Alitiásica

Colecistitis Aguda Alitiásica

colecistitis aguda alitiásica

2022

https://dialnet.unirioja.es/servlet/oaiart?codigo=8448476

1767464025928499200

dialnet-ar-18-ART00015310102023-05-30Colecistitis Aguda AlitiásicaCalle Jara, Emanuel FranciscoIdrovo Campoverde, Paula JesseniaPeralta Sánchez, Andrea GabrielaBermeo León, Karla JohannaQuilli Guamán, Jonnathan JavierColecistitisAgudaAlitiásicaDiagnósticoTratamientoCholecystitisAcuteAcalculousDiagnosisTreatmentAcute acalculous cholecystitis (AAC) or also called acalculous, is a rare but emerging entity and often secondary to other clinical con-ditions, manifests the presence of gallbladder inflammation in the absence of stones inside. Acalculous cholecystitis accounts for the remaining 5-10% of cholecystitis and is typically seen in very ill patients or in the setting of severe injury with predisposing factors (diabetes mellitus, vasculitis, heart failure, shock, sepsis, etc.) Diagnosis it is imperative, given its propensity for progression to gangrene (greater than 50%) and perforation (10%), and should be considered in all critically ill patients with sepsis and/or jaundice. Consequently, the pres-ent investigation has the purpose of summarizing the diagnosis and treatment of Acute Acalculous Cholecystitis. Laboratory studies are not conclusive in all patients (in some cases), however, the most recommended are: blood count with leukocytosis, elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), increased bilirubins, transaminases, alkaline phosphatase, amylase. For diag-nosis by means of images, due to the cost-effectiveness relationship, the echosonogram or ultrasound is the most used. Early treatment decision is closely related to prognosis. Treatment of CAA must always include antibiotic therapy and supportive treatment with fluids, analgesics and an initial absolute diet. Cholecystectomy has historically been the treatment of choice, however, currently percutaneous cholecystostomy has become an effective and minimally invasive alternative, especially in patients with high surgical risk.La colecistitis aguda alitiásica (CAA) o también llamada acalculosa, constituye en una entidad poco frecuente pero emergente y en mu-chas ocasiones secundaria a otras condiciones clínicas, manifiesta la presencia de una inflamación de la vesícula biliar en ausencia de cálculos en su interior. La colecistitis alitiásica representa el 5-10% restante de las colecistitis y se observa típicamente en pacientes muy enfermos o en el contexto de una lesión grave con factores predisponentes (diabetes mellitus, vasculitis, insuficiencia cardíaca, shock, sepsis, etc.) El diagnóstico es imperativo, dada su propensión para la progresión a la gangrena (más del 50%) y la perforación (10%) y debe considerarse en todos los pacientes críticos con septicemia y/o ictericia. En consecuencia, la presente investigación tiene el pro-pósito de compendiar el diagnóstico y tratamiento de la Colecistitis Aguda Alitiásica. Los estudios de laboratorio no son concluyentes en todos los pacientes (en algunos casos), sin embargo, los más recomendados son: biometría hemática con presencia de leucocitosis, elevación de proteína C reactiva (PCR) y de velocidad de sedimentación globular (VSG), aumento de bilirrubinas, transaminasas, fosfatasa alcalina, amilasa. Para el diagnóstico por medio de imágenes, debido a la relación costo-efectividad, es el ecosonograma o ultrasonido el más utilizado. La decisión temprana del tratamiento, está íntimamente relacionado con el pronóstico. El tratamiento de la CAA siempre ha de instaurarse antibioterapia y tratamiento de soporte con sueros, analgésicos y dieta absoluta inicial. La colecistectomía ha sido históricamente el tratamiento de elección, sin embargo, actualmente la colecistostomía percutánea se ha convertido en una alternativa eficaz y mínimamente invasiva, sobre todo en pacientes de alto riesgo quirúrgico.2022text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8448476(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 2, 2022, pags. 520-526spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI